FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kristian Wachtell

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Anatomy

Heart Ventricles

Physiology

Ventricular Function, Left

Co-author Network

Publications

TOP 3
Anders M Greve; Lars Køber; Christoph A Nienaber; Terje R Pedersen; Simon Ray; Anne B Rossebø; Kurt Boman; Kenneth Egstrup; Eva Gerdts; Christa Gohlke-Baerwolf; Ronnie Willenheimer; Kristian Wachtell
Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: The Simvastatin and Ezetimibe in Aortic Stenosis study.
Peter M Okin; Kristian Wachtell; Casper N Bang; Björn Dahlöf; Darcy A Hille; Sverre E Kjeldsen; Richard B Devereux
Relationship of sudden cardiac death to new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy.
Marina De Marco; Kurt Boman; Giuseppina Casalnuovo; Björn Dahlöf; Richard B Devereux; Eva Gerdts; Jorge R Kizer; Teresa Migliore; Michael H Olsen; Kristian Wachtell; Giovanni de Simone
Mitral annular calcification and incident ischemic stroke in treated hypertensive patients: the LIFE study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kristian Wachtell (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Anders M Greve; Lars Køber; Christoph A Nienaber; Terje R Pedersen; Simon Ray; Anne B Rossebø; Kurt Boman; Kenneth Egstrup; Eva Gerdts; Christa Gohlke-Baerwolf; Ronnie Willenheimer; Kristian Wachtell
Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: The Simvastatin and Ezetimibe in Aortic Stenosis study.
International journal of cardiology 2013;166(1):72-6.
2013: Peter M Okin; Kristian Wachtell; Casper N Bang; Björn Dahlöf; Darcy A Hille; Sverre E Kjeldsen; Richard B Devereux
Relationship of sudden cardiac death to new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy.
Circulation. Arrhythmia and electrophysiology 2013;6(2):243-51.
2013: Marina De Marco; Kurt Boman; Giuseppina Casalnuovo; Björn Dahlöf; Richard B Devereux; Eva Gerdts; Jorge R Kizer; Teresa Migliore; Michael H Olsen; Kristian Wachtell; Giovanni de Simone
Mitral annular calcification and incident ischemic stroke in treated hypertensive patients: the LIFE study.
American journal of hypertension 2013;26(4):567-73.
2013: Edda Bahlmann; John B Chambers; Dana Cramariuc; Eva Gerdts; Christa Gohlke-Baerwolf; Karl-Heinz Kuck; Christoph A Nienaber; Reinhard Seifert; Kristian Wachtell; Simon Ray
Prognostic value of energy loss index in asymptomatic aortic stenosis.
Circulation 2013;127(10):1149-56.
2013: Helle Søholm; Kristian Wachtell; Michael C J Wanscher; Jacob E Møller; Søren Loumann Nielsen; Frants Pedersen; Søren Boesgaard; John Bro-Jeppesen; Christian Hassager; Jesper Kjaergaard
Tertiary centres have improved survival compared to other hospitals in the Copenhagen area after out-of-hospital cardiac arrest.
Resuscitation 2013;84(2):162-7.
2013: Eva Gerdts; B P Lund; Markku S Nieminen; Peter M Okin; Kristian Wachtell; K Boman; Björn Dahlöf; G de Simone; R B Devereux
Impact of overweight and obesity on cardiac benefit of antihypertensive treatment.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2013;23(2):122-9.
2012: Casper N Bang; Anders M Greve; Kristian Wachtell; Lars Kober
Global systolic load, left ventricular hypertrophy, and atrial fibrillation.
American heart journal 2012;164(4):e13.
2012: Thomas Sehestedt; Christian Torp-Pedersen; Kristian Wachtell; Susanne Rasmussen; Tine W Hansen; Hans Ibsen; Jørgen Jeppesen; Michael H Olsen
Thresholds for pulse wave velocity, urine albumin creatinine ratio and left ventricular mass index using SCORE, Framingham and ESH/ESC risk charts.
Journal of hypertension 2012;30(10):1928-36.
2012: Anne Cecilie K Larstorp; Peter M Okin; Michael H Olsen; Björn Dahlöf; Richard B Devereux; Hans Ibsen; Sverre E Kjeldsen; Kristian Wachtell
Regression of ECG-LVH is associated with lower risk of new-onset heart failure and mortality in patients with isolated systolic hypertension; The LIFE study.
American journal of hypertension 2012;25(10):1101-9.
2012: Anders M Greve; Mai T Lønnebakken; Markku S Nieminen; Peter M Okin; Michael H Olsen; Per Omvik; Vittorio Palmieri; Jonathan Bella; Kurt Boman; Björn Dahlöf; Richard B Devereux; Eva Gerdts; Kristian Wachtell
Contrasting hemodynamic mechanisms of losartan- vs. atenolol-based antihypertensive treatment: a LIFE study.
American journal of hypertension 2012;25(9):1017-23.
2012: Anne Cecilie K Larstorp; Peter M Okin; Michael H Olsen; Inger Ariansen; Björn Dahlöf; Richard B Devereux; Knut Gjesdal; Hans Ibsen; Sverre E Kjeldsen; Kristian Wachtell
Association of pulse pressure with new-onset atrial fibrillation in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint (LIFE) reduction in hypertension study.
Hypertension 2012;60(2):347-53.
2012: Anne Christine H Ruwald; Thomas Sehestedt; Kristian Wachtell; Bo Westergaard; Björn Dahlöf; Richard B Devereux; Hans Ibsen; Sverre E Kjeldsen; Lars H Lindholm; Markku S Nieminen; Michael H Olsen
Losartan versus atenolol-based antihypertensive treatment reduces cardiovascular events especially well in elderly patients: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
Journal of hypertension 2012;30(6):1252-9.
2012: Eva Gerdts; Markku S Nieminen; Peter M Okin; Kristian Wachtell; Kurt Boman; Björn Dahlöf; Richard B Devereux
Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophy.
American journal of hypertension 2012;25(6):678-83.
2012: Casper N Bang; Kurt Boman; Kenneth Egstrup; Christa Gohlke-Baerwolf; Anders M Greve; Lars Køber; Christoph A Nienaber; Simon Ray; Anne B Rossebø; Kristian Wachtell
Effect of lipid lowering on new-onset atrial fibrillation in patients with asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study.
American heart journal 2012;163(4):690-6.
2012: Anders M Greve; Lars Køber; Simon Ray; Anne B Rossebø; Kurt Boman; Richard B Devereux; Eva Gerdts; Christa Gohlke-Baerwolf; Ronnie Willenheimer; Kristian Wachtell
Impact of QRS duration and morphology on the risk of sudden cardiac death in asymptomatic patients with aortic stenosis: the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study.
Journal of the American College of Cardiology 2012;59(13):1142-9.
2012: Thomas Sehestedt; Christian Torp-Pedersen; Kristian Wachtell; Susanne Rasmussen; Tine W Hansen; Hans Ibsen; Jørgen Jeppesen; Michael H Olsen
Can ambulatory blood pressure measurements substitute assessment of subclinical cardiovascular damage?
Journal of hypertension 2012;30(3):513-21.
2012: Ingar Holme; Y Antero Kesäniemi; William Malbecq; Terje R Pedersen; Simon Ray; Anne B Rossebø; Kristian Wachtell; Ronnie Willenheimer; Kurt Boman; Kenneth Egstrup; Eva Gerdts; Christa Gohlke-Bärwolf
A risk score for predicting mortality in patients with asymptomatic mild to moderate aortic stenosis.
Heart (British Cardiac Society) 2012;98(5):377-83.
2012: Inger Ariansen; Björn Dahlöf; Richard B Devereux; Knut Gjesdal; Hans Ibsen; Sverre E Kjeldsen; Peter M Okin; Michael H Olsen; Henrik M Reims; Kristian Wachtell
Impact of alcohol habits and smoking on the risk of new-onset atrial fibrillation in hypertensive patients with ECG left ventricular hypertrophy: the LIFE study.
Blood pressure 2012;21(1):6-11.
2012: Anders M Greve; Y Antero Kesäniemi; Lars Køber; Christoph Nienaber; Simon Ray; Anne B Rossebø; Kurt Boman; Richard B Devereux; Kenneth Egstrup; Christa Gohlke-Baerwolf; Ronnie Willenheimer; Kristian Wachtell
Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
Circulation 2012;125(2):346-53.
2011: Kristian Wachtell; Michael Hecht Olsen
Impaired left ventricular systolic function in patients with left ventricular hypertrophy.
Journal of hypertension 2011;29(11):2068-9.
2011: Mai T Lønnebakken; Kristian Wachtell; Kurt Boman; Björn Dahlöf; Eva Gerdts; Richard B Devereux
In-treatment stroke volume predicts cardiovascular risk in hypertension.
Journal of hypertension 2011;29(8):1508-14.
2011: Edda Bahlmann; Dana Cramariuc; Einar Davidsen; Richard B Devereux; Christa Gohlke-Baerwolf; Karl-Heinz Kuck; Christoph A Nienaber; Simon Ray; Kristian Wachtell; Eva Gerdts
Aortic root geometry in aortic stenosis patients (a SEAS substudy).
European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 2011;12(8):585-90.
2011: Michael H Olsen; Kristian Wachtell; Hans Ibsen; Lars Lindholm; Sverre E Kjeldsen; Per Omvik; Markku S Nieminen; Björn Dahlöf; Peter M Okin; Richard B Devereux
Changes in subclinical organ damage vs. in Framingham risk score for assessing cardiovascular risk reduction during continued antihypertensive treatment: a LIFE substudy.
Journal of hypertension 2011;29(5):997-1004.
2011: Nikolaus Jander; Jan Minners; Ingar Holme; Eva Gerdts; Kurt Boman; Philippe Brudi; John B Chambers; Kenneth Egstrup; Y Antero Kesäniemi; William Malbecq; Christoph A Nienaber; Simon Ray; Anne Rossebø; Terje R Pedersen; Terje Skjaerpe; Ronnie Willenheimer; Kristian Wachtell; Franz-Josef Neumann; Christa Gohlke-Bärwolf
Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fraction.
Circulation 2011;123(8):887-95.
2011: A C K Larstorp; P M Okin; R B Devereux; M H Olsen; H Ibsen; B Dahlöf; Sverre E Kjeldsen; Kristian Wachtell
Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study.
Journal of human hypertension 2011;25(3):178-85.
2010: Eva Gerdts; Anne Bjørhovde Rossebø; Terje R Pedersen; Kurt Boman; Philippe Brudi; John Boyd Chambers; Kenneth Egstrup; Christa Gohlke-Bärwolf; Ingar Holme; Y Antero Kesäniemi; William Malbecq; Christoph Nienaber; Simon Ray; Terje Skjaerpe; Kristian Wachtell; Ronnie Willenheimer
Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS study).
The American journal of cardiology 2010;106(11):1634-9.
2010: Kristian Wachtell; Vittorio Palmieri; Eva Gerdts; Jonathan Bella; Gerard P Aurigemma; Vasilios Papademetriou; Björn Dahlöf; Tapio Aalto; Hans Ibsen; Jens E Rokkedal; Richard B Devereux
Prognostic significance of left ventricular diastolic dysfunction in patients with left ventricular hypertrophy and systemic hypertension (the LIFE Study).
The American journal of cardiology 2010;106(7):999-1005.
2010: Benedicte P Wiik; Anne C K Larstorp; Aud Høieggen; Sverre E Kjeldsen; Michael Hecht Olsen; Hans Ibsen; Lars Lindholm; Björn Dahlöf; Richard B Devereux; Peter M Okin; Kristian Wachtell
Serum uric acid is associated with new-onset diabetes in hypertensive patients with left ventricular hypertrophy: The LIFE Study.
American journal of hypertension 2010;23(8):845-51.
2010: Peter M Okin; Eva Gerdts; Kristian Wachtell; Lasse Oikarinen; Markku S Nieminen; Björn Dahlöf; Richard B Devereux
Relationship of left atrial enlargement to persistence or development of ECG left ventricular hypertrophy in hypertensive patients: implications for the development of new atrial fibrillation.
Journal of hypertension 2010;28(7):1534-40.
2010: Kristian Wachtell; Eva Gerdts; Vittorio Palmieri; Michael H Olsen; Markku S Nieminen; Vasilios Papademetriou; Kurt Boman; Björn Dahlöf; Gerard P Aurigemma; Jens E Rokkedal; Richard B Devereux
In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study.
Journal of hypertension 2010;28(7):1541-6.
2010: Ingar Holme; Kurt Boman; Philippe Brudi; Kenneth Egstrup; Christa Gohlke-Baerwolf; Y Antero Kesäniemi; William Malbecq; Anne B Rossebø; Kristian Wachtell; Ronnie Willenheimer; Terje R Pedersen
Observed and predicted reduction of ischemic cardiovascular events in the Simvastatin and Ezetimibe in Aortic Stenosis trial.
The American journal of cardiology 2010;105(12):1802-8.
2010: Edda Bahlmann; Dana Cramariuc; Eva Gerdts; Christa Gohlke-Baerwolf; Christoph A Nienaber; Erlend Eriksen; Kristian Wachtell; John Chambers; Karl-Heinz Kuck; Simon Ray
Impact of pressure recovery on echocardiographic assessment of asymptomatic aortic stenosis: a SEAS substudy.
JACC. Cardiovascular imaging 2010;3(6):555-62.
2010: Kristian Wachtell; Eva Gerdts; Gerard P Aurigemma; Kurt Boman; Björn Dahlöf; Markku S Nieminen; Michael H Olsen; Peter M Okin; Vittorio Palmieri; Jens E Rokkedal; Richard B Devereux
In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study.
Blood pressure 2010;19(3):169-75.
2010: Nora Tuseth; Dana Cramariuc; Ashild E Rieck; Kristian Wachtell; Eva Gerdts
Asymmetric septal hypertrophy - a marker of hypertension in aortic stenosis (a SEAS substudy).
Blood pressure 2010;19(3):140-4.
2010: Camilla L Søraas; Kristian Wachtell; Peter M Okin; Björn Dahlöf; Richard B Devereux; Theis Tønnessen; Sverre E Kjeldsen; Michael H Olsen
Lack of regression of left ventricular hypertrophy is associated with higher incidence of revascularization in hypertension: The LIFE Study.
Blood pressure 2010;19(3):145-51.
2010: Markus P Schneider; Tsushung Hua; Michael Böhm; Kristian Wachtell; Sverre E Kjeldsen; Roland E Schmieder
Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis.
Journal of the American College of Cardiology 2010;55(21):2299-307.
2010: Thomas Sehestedt; Jørgen Jeppesen; Tine W Hansen; Kristian Wachtell; Hans Ibsen; Christian Torp-Pedersen; Christian Torp-Petersen; Per Hildebrandt; Michael H Olsen
Risk prediction is improved by adding markers of subclinical organ damage to SCORE.
European heart journal 2010;31(7):883-91.
2010: Ashild E Rieck; Dana Cramariuc; Eva M Staal; Anne B Rossebø; Kristian Wachtell; Eva Gerdts
Impact of hypertension on left ventricular structure in patients with asymptomatic aortic valve stenosis (a SEAS substudy).
Journal of hypertension 2010;28(2):377-83.
2010: Michael H Olsen; Thomas Sehestedt; Stig Lyngbaek; Tine W Hansen; Susanne Rasmussen; Kristian Wachtell; Christian Torp-Pedersen; Per R Hildebrandt; Hans Ibsen
Urine albumin/creatinine ratio, high sensitivity C-reactive protein and N-terminal pro brain natriuretic peptide--three new cardiovascular risk markers--do they improve risk prediction and influence treatment?
Current vascular pharmacology 2010;8(1):134-9.
2009: Thomas Sehestedt; Jørgen Jeppesen; Tine W Hansen; Susanne Rasmussen; Kristian Wachtell; Hans Ibsen; Christian Torp-Pedersen; Michael H Olsen
Risk stratification with the risk chart from the European Society of Hypertension compared with SCORE in the general population.
Journal of hypertension 2009;27(12):2351-7.
2009: Giovanni de Simone; Peter M Okin; Eva Gerdts; M H Olsen; Kristian Wachtell; Darcy A Hille; Björn Dahlöf; Sverre E Kjeldsen; Richard B Devereux
Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE study.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2009;19(9):634-40.
2009: Marcello Chinali; Gerard P Aurigemma; Giovanni de Simone; Rakesh K Mishra; Eva Gerdts; Kristian Wachtell; Kurt Boman; Björn Dahlöf; Richard B Devereux
Mitral E wave deceleration time to peak E velocity ratio and cardiovascular outcome in hypertensive patients during antihypertensive treatment (from the LIFE echo-substudy).
The American journal of cardiology 2009;104(8):1098-104.
2009: Kristian Wachtell; Niels Holmark Andersen; Tage Lysbo Svendsen
[Hypertension and the heart].
Ugeskrift for laeger 2009;171(25):2113-6.
2009: Thomas Sehestedt; Jørgen Jeppesen; Tine W Hansen; Susanne Rasmussen; Kristian Wachtell; Hans Ibsen; Christian Torp-Pedersen; Michael H Olsen
Which markers of subclinical organ damage to measure in individuals with high normal blood pressure?
Journal of hypertension 2009;27(6):1165-71.
2009: Lene Kjaer Olsen; Thomas Engstrøm; Kristian Wachtell; Thomas Kristensen; Christian Hassager; Nikolaj Ihlemann; Jacob Eifer Møller; Lars Willy Andersen; Peter Skov Olsen; Lars Søndergaard
[Transcatheter replacement of the aortic valve--a novel treatment modality for high-risk patients].
Ugeskrift for laeger 2009;171(15):1293-7.
2009: Lene Kjaer Olsen; Thomas Engstrøm; Kristian Wachtell; Thomas Kristensen; Christian Hassager; Nikolaj Ihlemann; Jacob Eifer Møller; Lars Willy Andersen; Peter Skov Olsen; Lars Søndergaard
[Percutaneous aortic valve replacement - initial experience and results].
Ugeskrift for laeger 2009;171(15):1289-93.
2009: Dana Cramariuc; Giovanni Cioffi; Ashild E Rieck; Richard B Devereux; Eva M Staal; Simon Ray; Kristian Wachtell; Eva Gerdts
Low-flow aortic stenosis in asymptomatic patients: valvular-arterial impedance and systolic function from the SEAS Substudy.
JACC. Cardiovascular imaging 2009;2(4):390-9.
2009: Kurt Boman; Eva Gerdts; Kristian Wachtell; Björn Dahlöf; Markku S Nieminen; Mona Olofsson; Vasilios Papademetriou; Richard B Devereux
Exercise and cardiovascular outcomes in hypertensive patients in relation to structure and function of left ventricular hypertrophy: the LIFE study.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2009;16(2):242-8.
2009: Michael H Olsen; Kristian Wachtell; Gareth Beevers; Björn Dahlöf; Giovanni de Simone; Richard B Devereux; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Sverre E Kjeldsen; Ole Lederballe-Pedersen; Lars H Lindholm; Paulette A Lyle; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study.
Journal of hypertension 2009;27(3):567-74.
2009: Kristian Wachtell
Prevention of congestive heart failure in high risk patients.
European heart journal 2009;30(6):638-9.
2009: Kristian Wachtell
Atrial fibrillation, maybe it is not so lone?
Journal of the American College of Cardiology 2009;53(1):30-1.
2009: Eva Gerdts; Stanley Franklin; Ashild Rieck; Vasilios Papademetriou; Kristian Wachtell; Markku Nieminen; Björn Dahlöf; Richard Blyton Devereux
Pulse pressure, left ventricular function and cardiovascular events during antihypertensive treatment (the LIFE study).
Blood pressure 2009;18(4):180-6.
2008: Peter M Okin; Kristian Wachtell; Sverre E Kjeldsen; Stevo Julius; Lars H Lindholm; Björn Dahlöf; Darcy A Hille; Markku S Nieminen; Jonathan M Edelman; Richard B Devereux
Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
Circulation. Arrhythmia and electrophysiology 2008;1(5):337-43.
2008: Kristian Wachtell; Richard B Devereux; Paulette A Lyle; Peter M Okin; Eva Gerdts
The left atrium, atrial fibrillation, and the risk of stroke in hypertensive patients with left ventricular hypertrophy.
Therapeutic advances in cardiovascular disease 2008;2(6):507-13.
2008: Kristian Wachtell; Michael H Olsen
Is it time to change the definition of normal urinary albumin excretion?
Nature clinical practice. Nephrology 2008;4(12):650-1.
2008: Eva Gerdts; Dana Cramariuc; Giovanni de Simone; Kristian Wachtell; Björn Dahlöf; Richard B Devereux
Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study).
European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 2008;9(6):809-15.
2008: Anne B Rossebø; Terje R Pedersen; Kurt Boman; Philippe Brudi; John B Chambers; Kenneth Egstrup; Eva Gerdts; Christa Gohlke-Bärwolf; Ingar Holme; Y Antero Kesäniemi; William Malbecq; Christoph A Nienaber; Simon Ray; Terje Skjaerpe; Kristian Wachtell; Ronnie Willenheimer
Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.
The New England journal of medicine 2008;359(13):1343-56.
2008: Michael H Olsen; T W Hansen; M K Christensen; F Gustafsson; S Rasmussen; Kristian Wachtell; Hans Ibsen; C Torp-Pedersen; Per Hildebrandt
Impact of the metabolic syndrome on the predictive values of new risk markers in the general population.
Journal of human hypertension 2008;22(9):634-40.
2008: Anders M Greve; Kristian Wachtell
Does lowering cholesterol have an impact on the progression of aortic stenosis?
Therapeutic advances in cardiovascular disease 2008;2(4):277-86.
2008: Marcello Chinali; Giovanni de Simone; Kristian Wachtell; Eva Gerdts; Julius M Gardin; Kurt Boman; Markku S Nieminen; Vasilios Papademetriou; Björn Dahlöf; Richard B Devereux
Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Journal of hypertension 2008;26(7):1472-6.
2008: Zhibin Li; Björn Dahlöf; Peter M Okin; Sverre E Kjeldsen; Kristian Wachtell; Hans Ibsen; Markku S Nieminen; Sverker Jern; Richard B Devereux
Left bundle branch block and cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension study.
Journal of hypertension 2008;26(6):1244-9.
2008: Vittorio Palmieri; Jonathan Bella; Eva Gerdts; Kristian Wachtell; Vasilios Papademetriou; Markku S Nieminen; Björn Dahlöf; Richard B Devereux
Change in pulse pressure/stroke index in response to sustained blood pressure reduction and its impact on left ventricular mass and geometry changes: the life study.
American journal of hypertension 2008;21(6):701-7.
2008: Morten Dalsgaard; Kenneth Egstrup; Kristian Wachtell; Eva Gerdts; Dana Cramariuc; Jesper Kjaergaard; Christian Hassager
Left atrial volume in patients with asymptomatic aortic valve stenosis (the Simvastatin and Ezetimibe in Aortic Stenosis study).
The American journal of cardiology 2008;101(7):1030-4.
2008: Silvana Cicala; Giovanni de Simone; Kristian Wachtell; Eva Gerdts; Kurt Boman; Markku S Nieminen; Björn Dahlöf; Richard B Devereux
Clinical impact of 'in-treatment' wall motion abnormalities in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Journal of hypertension 2008;26(4):806-12.
2008: Eva Gerdts; Peter M Okin; Giovanni de Simone; Dana Cramariuc; Kristian Wachtell; Kurt Boman; Richard B Devereux
Gender differences in left ventricular structure and function during antihypertensive treatment: the Losartan Intervention for Endpoint Reduction in Hypertension Study.
Hypertension 2008;51(4):1109-14.
2008: Peter M Okin; Kristian Wachtell; Richard B Devereux; Markku S Nieminen; Lasse Oikarinen; Matti Viitasalo; Lauri Toivonen; Hans Ibsen; Michael H Olsen; Knut Borch-Johnsen; Lars H Lindholm; Sverre E Kjeldsen; Stevo Julius; Björn Dahlöf
Combination of the electrocardiographic strain pattern and albuminuria for the prediction of new-onset heart failure in hypertensive patients: the LIFE study.
American journal of hypertension 2008;21(3):273-9.
2008: Dana Cramariuc; Ashild E Rieck; Eva M Staal; Kristian Wachtell; Erlend Eriksen; Anne B Rossebø; Eva Gerdts
Factors influencing left ventricular structure and stress-corrected systolic function in men and women with asymptomatic aortic valve stenosis (a SEAS Substudy).
The American journal of cardiology 2008;101(4):510-5.
2008: Michael H Olsen; Tine W Hansen; Marina K Christensen; Finn Gustafsson; Susanne Rasmussen; Kristian Wachtell; Hans Ibsen; Christian Torp-Pedersen; Per R Hildebrandt
Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.
Journal of hypertension 2008;26(1):26-34.
2008: Nana Valeur; Peter Clemmensen; Peer Grande; Kristian Wachtell; Kari Saunamaki
Pre-discharge exercise test for evaluation of patients with complete or incomplete revascularization following primary percutaneous coronary intervention: a DANAMI-2 sub-study.
Cardiology 2008;109(3):163-71.
2007: Matias Greve Lindholm; Thomas Engstrøm; Kristian Wachtell; Søren Boesgaard; Kåre Sander; Christian Hassager
[Percutaneous assist device during acute heart failure].
Ugeskrift for laeger 2007;169(39):3282-6.
2007: Lars Idorn; Dan Eik Høfsten; Kristian Wachtell; Henning Mølgaard; Kenneth Egstrup
Prevalence and prognostic implications of ST-segment deviations from ambulatory Holter monitoring after ST-segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy).
The American journal of cardiology 2007;100(6):937-43.
2007: Kristian Wachtell; Peter M Okin; Michael H Olsen; Björn Dahlöf; Richard B Devereux; Hans Ibsen; Sverre E Kjeldsen; Lars H Lindholm; Markku S Nieminen; Kristian Thygesen
Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.
Circulation 2007;116(7):700-5.
2007: Kristian Wachtell; Richard B Devereux; And Paulette A Lyle
The effect of angiotensin receptor blockers for preventing atrial fibrillation.
Current hypertension reports 2007;9(4):278-83.
2007: Giovanni de Simone; Michael H Olsen; Kristian Wachtell; Darcy A Hille; Björn Dahlöf; Hans Ibsen; Sverre E Kjeldsen; Paulette A Lyle; Richard B Devereux
Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study.
Journal of human hypertension 2007;21(8):625-32.
2007: Silvana Cicala; Richard B Devereux; Giovanni de Simone; Kristian Wachtell; Eva Gerdts; Kurt Boman; Markku S Nieminen; Vasilios Papademetriou; Björn Dahlöf; Peter M Okin
Electrocardiographic and echocardiographic detection of myocardial infarction in patients with left-ventricular hypertrophy. The LIFE Study.
American journal of hypertension 2007;20(7):771-6.
2007: Michael H Olsen; Tine W Hansen; Marina K Christensen; Finn Gustafsson; Susanne Rasmussen; Kristian Wachtell; Hans Ibsen; Christian Torp-Pedersen; Per R Hildebrandt
N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population.
European heart journal 2007;28(11):1374-81.
2007: Vittorio Palmieri; Peter M Okin; Giovanni de Simone; Jonathan Bella; Kristian Wachtell; Eva Gerdts; Kurt Boman; Markku S Nieminen; Björn Dahlöf; Richard B Devereux
Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
Journal of hypertension 2007;25(5):1079-85.
2007: Anne B Rossebø; Terje R Pedersen; Christopher Allen; Kurt Boman; John Chambers; Kenneth Egstrup; Eva Gerdts; Christa Gohlke-Bärwolf; Ingar Holme; V Antero Y Kesäniemi; William Malbecq; Christoph Nienaber; Simon Ray; Terje Skjaerpe; Kristian Wachtell; Ronnie Willenheimer
Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study.
The American journal of cardiology 2007;99(7):970-3.
2007: Wouter B A Eijkelkamp; Zhongxin Zhang; Barry M Brenner; Mark E Cooper; Richard B Devereux; Björn Dahlöf; Hans Ibsen; William F Keane; Lars H Lindholm; Michael H Olsen; Hans-Henrik Parving; Giuseppe Remuzzi; Shahnaz Shahinfar; Steven M Snapinn; Kristian Wachtell; Dick De Zeeuw
Renal function and risk for cardiovascular events in type 2 diabetic patients with hypertension: the RENAAL and LIFE studies.
Journal of hypertension 2007;25(4):871-6.
2007: Dan Eik Høfsten; Kristian Wachtell; Birgit Lund; Henning Mølgaard; Kenneth Egstrup
Prevalence and prognostic implications of non-sustained ventricular tachycardia in ST-segment elevation myocardial infarction after revascularization with either fibrinolysis or primary angioplasty.
European heart journal 2007;28(4):407-14.
2007: Eva Gerdts; Kristian Wachtell; Per Omvik; Jan Erik Otterstad; Lasse Oikarinen; Kurt Boman; Björn Dahlöf; Richard B Devereux
Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial.
Hypertension 2007;49(2):311-6.
2007: Lia E Bang; Niels Wiinberg; Kristian Wachtell; John Larsen; Michael H Olsen; Christian Tuxen; Per R Hildebrandt; Hans Ibsen
Losartan versus atenolol on 24-hour ambulatory blood pressure. A LIFE substudy.
Blood pressure 2007;16(6):392-7.
2006: Vittorio Palmieri; Peter M Okin; Jonathan Bella; Kristian Wachtell; Lasse Oikarinen; Eva Gerdts; Kurt Boman; Markku S Nieminen; Björn Dahlöf; Richard B Devereux
Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Journal of hypertension 2006;24(10):2079-84.
2006: Peter M Okin; Kristian Wachtell; Richard B Devereux; Katherine E Harris; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Lars H Lindholm; Markku S Nieminen; Jonathan Edelman; Darcy A Hille; Björn Dahlöf
Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension.
JAMA : the journal of the American Medical Association 2006;296(10):1242-8.
2006: Kristian Wachtell; Richard B Devereux; Paulette A Lyle
Use of beta-blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers to prevent atrial fibrillation.
Current cardiology reports 2006;8(5):356-64.
2006: Michael H Olsen; Kristian Wachtell; Olav Wendelboe Nielsen; Christian Hall; Ragnhild Wergeland; Hans Ibsen; Sverre E Kjeldsen; Richard B Devereux; Björn Dahlöf; Per R Hildebrandt
N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.
Journal of hypertension 2006;24(8):1531-9.
2006: Charlotte E Larroude; Berit T Jensen; Erik Agner; Egon Toft; Christian Torp-Pedersen; Kristian Wachtell; Jørgen K Kanters
Beat-to-beat QT dynamics in paroxysmal atrial fibrillation.
Heart rhythm : the official journal of the Heart Rhythm Society 2006;3(6):660-4.
2006: Michael H Olsen; Kristian Wachtell; Björn Dahlöf; R B Devereux; Hans Ibsen; S E Kjeldsen; Lars H Lindholm; Paulette A Lyle; Markku S Nieminen
The effect of losartan compared with atenolol on the incidence of revascularization in patients with hypertension and electrocardiographic left ventricular hypertrophy. The LIFE study.
Journal of human hypertension 2006;20(6):460-4.
2006: Puneet Narayan; Vasilios Papademetriou; Kristian Wachtell; Eva Gerdts; Kurt Boman; Markku S Nieminen; Giovanni de Simone; Björn Dahlöf; Frej Fyhrquist; Aud Hoieggen; Richard B Devereux
Association of hemoglobin delivery with left ventricular structure and function in hypertensive patients: Losartan Intervention for End Point Reduction in Hypertension Study.
Hypertension 2006;47(5):868-73.
2006: Michael H Olsen; Kristian Wachtell; Hans Ibsen; Lars H Lindholm; Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Lasse Oikarinen; Peter M Okin
Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE study.
Journal of hypertension 2006;24(4):775-81.
2006: Michael H Olsen; Marina K Christensen; Tine W Hansen; Finn Gustafsson; Susanne Rasmussen; Kristian Wachtell; Knut Borch-Johnsen; Hans Ibsen; Torben Jørgensen; Per Hildebrandt
High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors.
Journal of hypertension 2006;24(4):655-61.
2006: Eigil Fossum; Michael H Olsen; Aud Høieggen; Kristian Wachtell; Henrik M Reims; Sverre E Kjeldsen; Hans Ibsen; Ying Wan; Stevo Julius
Long-term effects of a losartan- compared with an atenolol-based treatment regimen on carotid artery plaque development in hypertensive patients with left ventricular hypertrophy: ICARUS, a LIFE substudy.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(3):169-73.
2006: Hans Ibsen; Michael H Olsen; Kristian Wachtell; Knut Borch-Johnsen; Lars H Lindholm; Carl E Mogensen; Björn Dahlöf; Steven M Snapinn; Ying Wan; Paulette A Lyle
Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE study.
Diabetes care 2006;29(3):595-600.
2006: Marina K Christensen; Michael H Olsen; Kristian Wachtell; Christian Tuxen; Eigil Fossum; Lia E Bang; Niels Wiinberg; Richard B Devereux; Sverre E Kjeldsen; Per Hildebrandt; Jens Rokkedal; Hans Ibsen
Does long-term losartan- vs atenolol-based antihypertensive treatment influence collagen markers differently in hypertensive patients? A LIFE substudy.
Blood pressure 2006;15(4):198-206.
2005: Andreas Kjaer; Christian Meyer; Kristian Wachtell; Michael H Olsen; Hans Ibsen; Lionel Opie; Søren Holm; Birger Hesse
Positron emission tomographic evaluation of regulation of myocardial perfusion in physiological (elite athletes) and pathological (systemic hypertension) left ventricular hypertrophy.
The American journal of cardiology 2005;96(12):1692-8.
2005: Michael H Olsen; Kristian Wachtell; Jonathan Bella; Vittorio Palmieri; Eva Gerdts; Gunnar Smith; Markku S Nieminen; Björn Dahlöf; Hans Ibsen; Richard B Devereux
Aortic valve sclerosis and albuminuria predict cardiovascular events independently in hypertension: a losartan intervention for endpoint-reduction in hypertension (LIFE) substudy.
American journal of hypertension 2005;18(11):1430-6.
2005: Michael H Olsen; Tine W Hansen; Marina K Christensen; Finn Gustafsson; Susanne Rasmussen; Kristian Wachtell; Knut Borch-Johnsen; Hans Ibsen; Torben Jørgensen; Per Hildebrandt
N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome.
Hypertension 2005;46(4):660-6.
2005: Stanley S Franklin; Kristian Wachtell; Vasilios Papademetriou; Michael H Olsen; Richard B Devereux; Frej Fyhrquist; Hans Ibsen; Sverre E Kjeldsen; Björn Dahlöf
Cardiovascular morbidity and mortality in hypertensive patients with lower versus higher risk: a LIFE substudy.
Hypertension 2005;46(3):492-9.
2005: Michael H Olsen; Kristian Wachtell; Christian Tuxen; Eigil Fossum; Lia E Bang; Christian Hall; Hans Ibsen; Jens Rokkedal; Richard B Devereux; Per R Hildebrandt
Opposite effects of losartan and atenolol on natriuretic peptides in patients with hypertension and left ventricular hypertrophy: a LIFE substudy.
Journal of hypertension 2005;23(5):1083-90.
2005: Giovanni de Simone; Kristian Wachtell; Vittorio Palmieri; Darcy A Hille; Gareth Beevers; Björn Dahlöf; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Stevo Julius; Sverre E Kjeldsen; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Richard B Devereux
Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: the LIFE (Losartan Intervention For Endpoint reduction in hypertension) study.
Circulation 2005;111(15):1924-31.
2005: Berit T Jensen; Steen Z Abildstrom; Charlotte E Larroude; Erik Agner; Christian Torp-Pedersen; Ole Nyvad; Michael Ottesen; Kristian Wachtell; Jørgen K Kanters
QT dynamics in risk stratification after myocardial infarction.
Heart rhythm : the official journal of the Heart Rhythm Society 2005;2(4):357-64.
2005: Michael H Olsen; Eigil Fossum; Aud Høieggen; Kristian Wachtell; Elsa Hjerkinn; Shawna D Nesbitt; Ulrik B Andersen; Robert A Phillips; Cynthia L Gaboury; Hans Ibsen; Sverre E Kjeldsen; Stevo Julius
Long-term treatment with losartan versus atenolol improves insulin sensitivity in hypertension: ICARUS, a LIFE substudy.
Journal of hypertension 2005;23(4):891-8.
2005: Michael H Olsen; Marina K Christensen; Kristian Wachtell; Christian Tuxen; Eigil Fossum; Lia E Bang; Niels Wiinberg; Richard B Devereux; Sverre E Kjeldsen; Per Hildebrandt; Harriet Dige-Petersen; Jens Rokkedal; Hans Ibsen
Markers of collagen synthesis is related to blood pressure and vascular hypertrophy: a LIFE substudy.
Journal of human hypertension 2005;19(4):301-7.
2005: Kristian Wachtell; Mika Lehto; Eva Gerdts; Michael H Olsen; Björn Hornestam; Björn Dahlöf; Hans Ibsen; Stevo Julius; Sverre E Kjeldsen; Lars H Lindholm; Markku S Nieminen; Richard B Devereux
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
Journal of the American College of Cardiology 2005;45(5):712-9.
2005: Kristian Wachtell; Björn Hornestam; Mika Lehto; David Slotwiner; Eva Gerdts; Michael H Olsen; Peter Aurup; Björn Dahlöf; Hans Ibsen; Stevo Julius; Sverre E Kjeldsen; Lars H Lindholm; Markku S Nieminen; Jens Rokkedal; Richard B Devereux
Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
Journal of the American College of Cardiology 2005;45(5):705-11.
2005: Hans Ibsen; Michael H Olsen; Kristian Wachtell; Knut Borch-Johnsen; Lars H Lindholm; Carl Erik Mogensen; Björn Dahlöf; Richard B Devereux; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Ying Wan
Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study.
Hypertension 2005;45(2):198-202.
2005: Kurt Boman; Mona Olofsson; Björn Dahlöf; Eva Gerdts; Markku S Nieminen; Vasilios Papademetriou; Kristian Wachtell; Richard B Devereux
Left ventricular structure and function in sedentary and physically active subjects with left ventricular hypertrophy (the LIFE Study).
The American journal of cardiology 2005;95(2):280-3.
2005: Michael H Olsen; Kristian Wachtell; Keld Neland; Jonathan Bella; Jens Rokkedal; Harriet Dige-Petersen; Hans Ibsen
Losartan but not atenolol reduce carotid artery hypertrophy in essential hypertension. A LIFE substudy.
Blood pressure 2005;14(3):177-83.
2005: Michael H Olsen; Kristian Wachtell; Jonathan Bella; Eva Gerdts; Vittorio Palmieri; Markku S Nieminen; Gunnar Smith; Hans Ibsen; Richard B Devereux
Aortic valve sclerosis relates to cardiovascular events in patients with hypertension (a LIFE substudy).
The American journal of cardiology 2005;95(1):132-6.
2005: Jorge R Kizer; Björn Dahlöf; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Kristian Wachtell; Jonathan Edelman; Steven M Snapinn; Katherine E Harris; Richard B Devereux
Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study.
Hypertension 2005;45(1):46-52.
2004: Richard B Devereux; Kristian Wachtell; Eva Gerdts; Kurt Boman; Markku S Nieminen; Vasilios Papademetriou; Jens Rokkedal; Katherine Harris; Peter Aurup; Björn Dahlöf
Prognostic significance of left ventricular mass change during treatment of hypertension.
JAMA : the journal of the American Medical Association 2004;292(19):2350-6.
2004: Hans Ibsen; Kristian Wachtell; Michael H Olsen; Knut Borch-Johnsen; Lars H Lindholm; Carl Erik Mogensen; Björn Dahlöf
Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE Study.
Kidney international. Supplement 2004;(92):S56-8.
2004: Michael H Olsen; Kristian Wachtell; Jonathan Bella; Jennifer E Liu; Kurt Boman; Eva Gerdts; Vasilios Papademetriou; Markku S Nieminen; Jens Rokkedal; Björn Dahlöf; Richard B Devereux
Effect of losartan versus atenolol on aortic valve sclerosis (a LIFE substudy).
The American journal of cardiology 2004;94(8):1076-80.
2004: Richard B Devereux; Björn Dahlöf; Eva Gerdts; Kurt Boman; Markku S Nieminen; Vasilios Papademetriou; Jens Rokkedal; Katherine E Harris; Jonathan Edelman; Kristian Wachtell
Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.
Circulation 2004;110(11):1456-62.
2004: Kristian Wachtell; Vasilios Papademetriou; Gunnar Smith; Eva Gerdts; Björn Dahlöf; Erik Engblom; Gerard P Aurigemma; Jonathan Bella; Hans Ibsen; Jens Rokkedal; Richard B Devereux
Relation of impaired left ventricular filling to systolic midwall mechanics in hypertensive patients with normal left ventricular systolic chamber function: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study.
American heart journal 2004;148(3):538-44.
2004: Hans Ibsen; Kristian Wachtell; Michael H Olsen; Knut Borch-Johnsen; Lars H Lindholm; Carl Erik Mogensen; Björn Dahlöf; Richard B Devereux; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Ying Wan
Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy.
Journal of hypertension 2004;22(9):1805-11.
2004: Michael H Olsen; Kristian Wachtell; Christian Tuxen; Eigil Fossum; Lia E Bang; Christian Hall; Hans Ibsen; Jens Rokkedal; Richard B Devereux; Per Hildebrandt
N-terminal pro-brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy: a LIFE study.
Journal of hypertension 2004;22(8):1597-604.
2004: Eva Gerdts; M J Roman; V Palmieri; Kristian Wachtell; G Smith; M S Nieminen; B Dahlöf; Richard B Devereux
Impact of age on left ventricular hypertrophy regression during antihypertensive treatment with losartan or atenolol (the LIFE study).
Journal of human hypertension 2004;18(6):417-22.
2004: Michael H Olsen; Kristian Wachtell; Jonathan Bella; Vittorio Palmieri; Eva Gerdts; G Smith; Markku S Nieminen; B Dahlöf; Hans Ibsen; Richard B Devereux
Albuminuria predicts cardiovascular events independently of left ventricular mass in hypertension: a LIFE substudy.
Journal of human hypertension 2004;18(6):453-9.
2004: Z B Li; Kristian Wachtell; Peter M Okin; Eva Gerdts; Jennifer E Liu; Markku S Nieminen; Sverker Jern; Björn Dahlöf; Richard B Devereux
Association of left bundle branch block with left ventricular structure and function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Journal of human hypertension 2004;18(6):397-402.
2004: Niels Wiinberg; Lia E Bang; Kristian Wachtell; J Larsen; Michael H Olsen; Christian Tuxen; Per R Hildebrandt; Jens Rokkedal; Hans Ibsen; Richard B Devereux
24-h Ambulatory blood pressure in patients with ECG-determined left ventricular hypertrophy: left ventricular geometry and urinary albumin excretion-a LIFE substudy.
Journal of human hypertension 2004;18(6):391-6.
2004: Eigil Fossum; Michael H Olsen; Aud Høieggen; Kristian Wachtell; Henrik M Reims; Hans Ibsen; Stevo Julius; Sverre E Kjeldsen
Long-term plasma catecholamines in patients with hypertension and left ventricular hypertrophy treated with losartan or atenolol: ICARUS, a LIFE substudy.
Journal of human hypertension 2004;18(6):375-80.
2004: Peter M Okin; Richard B Devereux; Jennifer E Liu; Lasse Oikarinen; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Kristian Wachtell; Markku S Nieminen; Björn Dahlöf
Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study.
Journal of human hypertension 2004;18(6):403-9.
2004: Jonathan Bella; Vittorio Palmieri; Kristian Wachtell; Jennifer E Liu; Eva Gerdts; Markku S Nieminen; MJ Koren; Miguel Zabalgoitia; J T Wright; Björn Dahlöf; Richard B Devereux
Sex-related difference in regression of left ventricular hypertrophy with antihypertensive treatment: the LIFE study.
Journal of human hypertension 2004;18(6):411-6.
2004: Michael H Olsen; Kristian Wachtell; G de Simone; Vittorio Palmieri; Harriet Dige-Petersen; Richard B Devereux; Hans Ibsen; Jens Rokkedal
Is inappropriate left ventricular mass related to neurohormonal factors and/or arterial changes in hypertension? A LIFE substudy.
Journal of human hypertension 2004;18(6):437-43.
2004: Michael H Olsen; Kristian Wachtell; Christian Meyer; Jens D Hove; Vittorio Palmieri; Harriet Dige-Petersen; Jens Rokkedal; Birger Hesse; Hans Ibsen
Association between vascular dysfunction and reduced myocardial flow reserve in patients with hypertension: a LIFE substudy.
Journal of human hypertension 2004;18(6):445-52.
2004: Vittorio Palmieri; Kristian Wachtell; Jonathan Bella; Eva Gerdts; Vasilios Papademetriou; Markku S Nieminen; Björn Dahlöf; M J Roman; Richard B Devereux
Usefulness of the assessment of the appropriateness of left ventricular mass to detect left ventricular systolic and diastolic abnormalities in absence of echocardiographic left ventricular hypertrophy: the LIFE study.
Journal of human hypertension 2004;18(6):423-30.
2004: Per Hildebrandt; Mikael Boesen; Michael Olsen; Kristian Wachtell; Bjoern A Groenning
N-terminal pro brain natriuretic peptide in arterial hypertension--a marker for left ventricular dimensions and prognosis.
European journal of heart failure 2004;6(3):313-7.
2003: Kristian Wachtell; Hans Ibsen; Michael H Olsen; Knut Borch-Johnsen; Lars H Lindholm; Carl Erik Mogensen; Björn Dahlöf; Richard B Devereux; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Krister Kristianson; Ole Lederballe-Pedersen; Markku S Nieminen; Peter M Okin; Per Omvik; Suzanne Oparil; Hans Wedel; Steven M Snapinn; Peter Aurup
Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Annals of internal medicine 2003;139(11):901-6.
2003: Lars H Lindholm; Björn Dahlöf; Jonathan Edelman; Hans Ibsen; Knut Borch-Johnsen; Michael H Olsen; Steven M Snapinn; Kristian Wachtell
Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE study.
Lancet 2003;362(9384):619-20.
2003: Lasse Oikarinen; Markku S Nieminen; Lauri Toivonen; Matti Viitasalo; Kristian Wachtell; Vasilios Papademetriou; Sverker Jern; Björn Dahlöf; Richard B Devereux; Peter M Okin
Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan Intervention For Endpoint Reduction (LIFE) study.
American heart journal 2003;145(5):919-25.
2003: Michael H Olsen; Elsa Hjerkinn; Kristian Wachtell; Aud Høieggen; Jonathan Bella; Shawna D Nesbitt; Eigil Fossum; Sverre E Kjeldsen; Stevo Julius; Hans Ibsen
Are left ventricular mass, geometry and function related to vascular changes and/or insulin resistance in long-standing hypertension? ICARUS: a LIFE substudy.
Journal of human hypertension 2003;17(5):305-11.
2003: Vittorio Palmieri; Jonathan Bella; Mary J Roman; Eva Gerdts; Vasilios Papademetriou; Kristian Wachtell; Markku S Nieminen; Björn Dahlöf; Richard B Devereux
Pulse pressure/stroke index and left ventricular geometry and function: the LIFE Study.
Journal of hypertension 2003;21(4):781-7.
2003: Gerard P Aurigemma; Richard B Devereux; Kristian Wachtell; Vittorio Palmieri; Kurt Boman; Eva Gerdts; Markku S Nieminen; Vasilios Papademetriou; Björn Dahlöf
Left ventricular mass regression in the LIFE study: effect of previous antihypertensive treatment.
American journal of hypertension 2003;16(3):180-6.
2003: Steen Z Abildstrom; Berit T Jensen; Erik Agner; Christian Torp-Pedersen; Ole Nyvad; Kristian Wachtell; Michael Ottesen; Jørgen K Kanters
Heart rate versus heart rate variability in risk prediction after myocardial infarction.
Journal of cardiovascular electrophysiology 2003;14(2):168-73.
2003: Vittorio Palmieri; Peter M Okin; Jonathan Bella; Eva Gerdts; Kristian Wachtell; Julius Gardin; Vasilios Papademetriou; Markku S Nieminen; Björn Dahlöf; Richard B Devereux
Echocardiographic wall motion abnormalities in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
Hypertension 2003;41(1):75-82.
2002: Kristian Wachtell; Björn Dahlöf; Jens Rokkedal; Vasilios Papademetriou; Markku S Nieminen; Gunnar Smith; Eva Gerdts; Kurt Boman; Jonathan Bella; Richard B Devereux
Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
American heart journal 2002;144(6):1057-64.
2002: Michael H Olsen; Kristian Wachtell; Kristine L Hermann; Erik Frandsen; Harriet Dige-Petersen; Jens Rokkedal; Richard B Devereux; Hans Ibsen
Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension.
American heart journal 2002;144(3):530-7.
2002: Lars H Lindholm; Hans Ibsen; Knut Borch-Johnsen; Michael H Olsen; Kristian Wachtell; Björn Dahlöf; Richard B Devereux; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Krister Kristianson; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Peter Aurup; Jonathan Edelman; Steven M Snapinn
Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study.
Journal of hypertension 2002;20(9):1879-86.
2002: Kristian Wachtell; Vittorio Palmieri; Michael H Olsen; Eva Gerdts; Vasilios Papademetriou; Markku S Nieminen; Gunnar Smith; Björn Dahlöf; Gerard P Aurigemma; Richard B Devereux
Change in systolic left ventricular performance after 3 years of antihypertensive treatment: the Losartan Intervention for Endpoint (LIFE) Study.
Circulation 2002;106(2):227-32.
2002: Richard B Devereux; Vittorio Palmieri; Jennifer E Liu; Kristian Wachtell; Jonathan Bella; Kurt Boman; Eva Gerdts; Markku S Nieminen; Vasilios Papademetriou; Björn Dahlöf
Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction study.
Journal of hypertension 2002;20(7):1445-50.
2002: Michael H Olsen; Kristian Wachtell; Christian Aalkjaer; Harriet Dige-Petersen; Jens Rokkedal; Hans Ibsen
Vasodilatory capacity and vascular structure in long-standing hypertension: a LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension.
American journal of hypertension 2002;15(5):398-404.
2002: Kristian Wachtell; Jonathan Bella; Jens Rokkedal; Vittorio Palmieri; Vasilios Papademetriou; Björn Dahlöf; Tapio Aalto; Eva Gerdts; Richard B Devereux
Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study.
Circulation 2002;105(9):1071-6.
2002: Eva Gerdts; Lasse Oikarinen; Vittorio Palmieri; Jan Erik Otterstad; Kristian Wachtell; Kurt Boman; Björn Dahlöf; Richard B Devereux
Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study.
Hypertension 2002;39(3):739-43.
2002: Kristian Wachtell; Michael H Olsen; Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Markku S Nieminen; Peter M Okin; Vasilios Papademetriou; Carl E Mogensen; Knut Borch-Johnsen; Hans Ibsen
Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study.
Journal of hypertension 2002;20(3):405-12.
2002: Eva Gerdts; Vasilios Papademetriou; Vittorio Palmieri; Kurt Boman; Hans Björnstad; Kristian Wachtell; Thomas D Giles; Björn Dahlöf; Richard B Devereux
Correlates of pulse pressure reduction during antihypertensive treatment (losartan or atenolol) in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study).
The American journal of cardiology 2002;89(4):399-402.
2002: Johan Herlitz; John Wikstrand; Marty Denny; Paul Fenster; Thomas Heywood; Gabriella Masszi; Sten Rasmussen; Gudmundur Thorgeirsson; Kristian Wachtell
Effects of metoprolol CR/XL on mortality and hospitalizations in patients with heart failure and history of hypertension.
Journal of cardiac failure 2002;8(1):8-14.
2002: Kristian Wachtell; Vittorio Palmieri; Michael H Olsen; Jonathan Bella; Tapio Aalto; Björn Dahlöf; Eva Gerdts; Jackson T Wright; Vasilios Papademetriou; Carl E Mogensen; Knut Borch-Johnsen; Hans Ibsen; Richard B Devereux
Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction.
American heart journal 2002;143(2):319-26.
2002: Jonathan Bella; Kristian Wachtell; Kurt Boman; Vittorio Palmieri; Vasilios Papademetriou; Eva Gerdts; Tapio Aalto; Michael H Olsen; Mona Olofsson; Björn Dahlöf; Mary J Roman; Richard B Devereux
Relation of left ventricular geometry and function to aortic root dilatation in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study).
The American journal of cardiology 2002;89(3):337-41.
2002: Michael H Olsen; Kristian Wachtell; Kristine L Hermann; Jonathan Bella; Harriet Dige-Petersen; Jens Rokkedal; Hans Ibsen
Left ventricular hypertrophy is associated with reduced vasodilatory capacity in the brachial artery in patients with longstanding hypertension. A LIFE substudy.
Blood pressure 2002;11(5):285-92.
2001: Michael H Olsen; Kristian Wachtell; Kristine L Hermann; Jonathan Bella; Ulrik B Andersen; Harriet Dige-Petersen; Jens Rokkedal; Hans Ibsen
Maximal exercise capacity is related to cardiovascular structure in patients with longstanding hypertension. A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension.
American journal of hypertension 2001;14(12):1205-10.
2001: Lasse Oikarinen; Markku S Nieminen; Matti Viitasalo; Lauri Toivonen; Kristian Wachtell; Vasilios Papademetriou; Sverker Jern; Björn Dahlöf; Richard B Devereux; Peter M Okin
Relation of QT interval and QT dispersion to echocardiographic left ventricular hypertrophy and geometric pattern in hypertensive patients. The LIFE study. The Losartan Intervention For Endpoint Reduction.
Journal of hypertension 2001;19(10):1883-91.
2001: Michael H Olsen; Kristian Wachtell; Christian Aalkjaer; Richard B Devereux; Harriet Dige-Petersen; Hans Ibsen
Endothelial dysfunction in resistance arteries is related to high blood pressure and circulating low density lipoproteins in previously treated hypertension.
American journal of hypertension 2001;14(9 Pt 1):861-7.
2001: Vasilios Papademetriou; R B Devereux; P Narayan; Kristian Wachtell; Jonathan Bella; E Gerdts; S G Chrysant; B Dahlöf
Similar effects of isolated systolic and combined hypertension on left ventricular geometry and function: the LIFE Study.
American journal of hypertension 2001;14(8 Pt 1):768-74.
2001: Vittorio Palmieri; Kristian Wachtell; Eva Gerdts; Jonathan Bella; Vasilios Papademetriou; Christian Tuxen; Markku S Nieminen; Björn Dahlöf; Giovanni de Simone; Richard B Devereux
Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the LIFE study.
American heart journal 2001;141(5):784-91.
2001: Richard Devereux; Jonathan Bella; Kurt Boman; Eva Gerdts; Markku S Nieminen; Jens Rokkedal; Vasilios Papademetriou; Kristian Wachtell; J Wright; Mary Paranicas; Peter M Okin; Mary J Roman; G Smith; Björn Dahlöf
Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study.
Blood pressure 2001;10(2):74-82.
2001: Jonathan Bella; Kristian Wachtell; Vittorio Palmieri; P R Liebson; Eva Gerdts; A Ylitalo; MJ Koren; O L Pedersen; Jens Rokkedal; Björn Dahlöf; Mary J Roman; Richard B Devereux
Relation of left ventricular geometry and function to systemic hemodynamics in hypertension: the LIFE Study. Losartan Intervention For Endpoint Reduction in Hypertension Study.
Journal of hypertension 2001;19(1):127-34.
2001: Kristian Wachtell; Jens Rokkedal; Jonathan Bella; Tapio Aalto; Björn Dahlöf; G Smith; Mary J Roman; Hans Ibsen; Gerard P Aurigemma; Richard B Devereux
Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (The LIFE Study). Losartan Intervention For Endpoint.
The American journal of cardiology 2001;87(1):54-60.
2000: Kristian Wachtell; G Smith; Eva Gerdts; Björn Dahlöf; Markku S Nieminen; Vasilios Papademetriou; Jonathan Bella; Hans Ibsen; Jens Rokkedal; Richard B Devereux
Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Losartan Intervention For Endpoint.
The American journal of cardiology 2000;85(4):466-72.
2000: Michael H Olsen; Ulrik B Andersen; Kristian Wachtell; Hans Ibsen; Harriet Dige-Petersen
A possible link between endothelial dysfunction and insulin resistance in hypertension. A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension.
Blood pressure 2000;9(2-3):132-9.
2000: Michael H Olsen; Eigil Fossum; Elsa Hjerkinn; Kristian Wachtell; Aud Høieggen; Shawna D Nesbitt; Ulrik B Andersen; R A Phillips; C L Gaboury; Hans Ibsen; Sverre E Kjeldsen; Stevo Julius
Relative influence of insulin resistance versus blood pressure on vascular changes in longstanding hypertension. ICARUS, a LIFE sub study. Insulin Carotids US Scandinavia.
Journal of hypertension 2000;18(1):75-81.
2000: Kristian Wachtell; Jonathan Bella; P R Liebson; Eva Gerdts; Björn Dahlöf; Tapio Aalto; Mary J Roman; Vasilios Papademetriou; Hans Ibsen; Jens Rokkedal; Richard B Devereux
Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population : the LIFE study.
Hypertension 2000;35(1 Pt 1):6-12.
1999: Michael H Olsen; Ulrik B Andersen; Kristian Wachtell; Hans Ibsen; Harriet Dige-Petersen
Influence of non-steady state during isoglycemic hyperinsulinemic clamp in hypertension. A LIFE substudy.
Blood pressure 1999;8(4):207-13.